164 related articles for article (PubMed ID: 25398068)
1. Cardiovascular disease in HIV: traditional and nontraditional risk factors.
Grinspoon SK
Top Antivir Med; 2014; 22(4):676-9. PubMed ID: 25398068
[TBL] [Abstract][Full Text] [Related]
2. Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease.
Currier JS
Top Antivir Med; 2018 Apr; 25(4):133-137. PubMed ID: 29689541
[TBL] [Abstract][Full Text] [Related]
3. Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.
Top HIV Med; 2010 Dec; 18(5):164-8. PubMed ID: 21245517
[TBL] [Abstract][Full Text] [Related]
4. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.
Deeks SG
Top HIV Med; 2009; 17(4):118-23. PubMed ID: 19890183
[TBL] [Abstract][Full Text] [Related]
5. Aging and HIV infection: focus on cardiovascular disease risk.
Aberg JA
Top Antivir Med; 2020 Jan; 27(4):102-105. PubMed ID: 32224501
[TBL] [Abstract][Full Text] [Related]
6. Metabolic complications of HIV infection and its therapies.
Overton ET
Top Antivir Med; 2014; 22(3):651-4. PubMed ID: 25101530
[TBL] [Abstract][Full Text] [Related]
7. HIV Infection: Advances Toward a Cure.
Douek DC
Top Antivir Med; 2018 Apr; 25(4):121-125. PubMed ID: 29689537
[TBL] [Abstract][Full Text] [Related]
8. Management of Lipid Levels and Cardiovascular Disease in HIV-Infected Individuals: Just Give Them a Statin?
Stein JH
Top Antivir Med; 2016 Dec-2017 Jan; 23(5):169-73. PubMed ID: 27398770
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk and dyslipidemia management in HIV-infected patients.
Stein JH
Top Antivir Med; 2012; 20(4):129-33; quiz 123-4. PubMed ID: 23154252
[TBL] [Abstract][Full Text] [Related]
10. Update on cardiovascular complications in HIV infection.
Currier JS
Top HIV Med; 2009; 17(3):98-103. PubMed ID: 19675367
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Complications of HIV Infection.
Glesby MJ
Top Antivir Med; 2017; 24(4):127-131. PubMed ID: 28208120
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular implications from untreated human immunodeficiency virus infection.
Baker JV; Lundgren JD
Eur Heart J; 2011 Apr; 32(8):945-51. PubMed ID: 21228007
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk and risk management in HIV-infected patients.
Adeyemi O
Top HIV Med; 2007; 15(5):159-62. PubMed ID: 18073451
[TBL] [Abstract][Full Text] [Related]
14. Predicting and preventing cardiovascular disease in HIV-infected patients.
Post WS
Top Antivir Med; 2011 Dec; 19(5):169-73. PubMed ID: 22298885
[TBL] [Abstract][Full Text] [Related]
15. Lipid metabolism and cardiovascular risk in HIV infection: new perspectives and the role of nevirapine.
Podzamczer D
AIDS Rev; 2013; 15(4):195-203. PubMed ID: 24192600
[TBL] [Abstract][Full Text] [Related]
16. Subclinical atherosclerosis in low Framingham risk HIV patients.
León R; Reus S; López N; Portilla I; Sánchez-Payá J; Giner L; Boix V; Merino E; Torrús D; Moreno-Pérez Ó; Portilla J
Eur J Clin Invest; 2017 Aug; 47(8):591-599. PubMed ID: 28664622
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.
Kaplan-Lewis E; Aberg JA; Lee M
Curr HIV/AIDS Rep; 2016 Oct; 13(5):297-308. PubMed ID: 27562769
[TBL] [Abstract][Full Text] [Related]
18. What do we need to do to cure HIV infection.
Siliciano RF
Top HIV Med; 2010; 18(3):104-8. PubMed ID: 20921575
[TBL] [Abstract][Full Text] [Related]
19. Maximizing the Benefits of HIV Preexposure Prophylaxis.
Buchbinder SP
Top Antivir Med; 2018 Apr; 25(4):138-142. PubMed ID: 29689539
[TBL] [Abstract][Full Text] [Related]
20. HIV infection and cardiovascular disease.
Hemkens LG; Bucher HC
Eur Heart J; 2014 Jun; 35(21):1373-81. PubMed ID: 24408888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
